IDYA logo

IDEAYA Biosciences, Inc. (IDYA) Accounts Payable

Annual Accounts Payable:

$15.42M+$8.82M(+133.72%)
December 31, 2024

Summary

  • As of today, IDYA annual accounts payable is $15.42 million, with the most recent change of +$8.82 million (+133.72%) on December 31, 2024.
  • During the last 3 years, IDYA annual accounts payable has risen by +$13.32 million (+634.33%).
  • IDYA annual accounts payable is now at all-time high.

Performance

IDYA Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDYAbalance sheet metrics

Quarterly Accounts Payable:

$18.43M+$1.16M(+6.73%)
September 30, 2025

Summary

  • As of today, IDYA quarterly accounts payable is $18.43 million, with the most recent change of +$1.16 million (+6.73%) on September 30, 2025.
  • Over the past year, IDYA quarterly accounts payable has increased by +$5.87 million (+46.68%).
  • IDYA quarterly accounts payable is now at all-time high.

Performance

IDYA Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDYAbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

IDYA Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+133.7%+46.7%
3Y3 Years+634.3%+405.7%
5Y5 Years+2075.0%+1212.0%

IDYA Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+634.3%at high+405.7%
5Y5-Yearat high+2075.0%at high+1834.2%
All-TimeAll-Timeat high+2229.5%at high+2594.9%

IDYA Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$18.43M(+6.7%)
Jun 2025
-
$17.27M(-2.0%)
Mar 2025
-
$17.63M(+14.3%)
Dec 2024
$15.42M(+133.7%)
$15.42M(+22.7%)
Sep 2024
-
$12.57M(-20.9%)
Jun 2024
-
$15.89M(+152.6%)
Mar 2024
-
$6.29M(-4.7%)
Dec 2023
$6.60M(+54.2%)
$6.60M(+27.6%)
Sep 2023
-
$5.17M(-11.9%)
Jun 2023
-
$5.87M(+34.1%)
Mar 2023
-
$4.38M(+2.2%)
Dec 2022
$4.28M
$4.28M(+17.4%)
Sep 2022
-
$3.65M(-13.8%)
Jun 2022
-
$4.23M(+25.7%)
DateAnnualQuarterly
Mar 2022
-
$3.36M(+60.2%)
Dec 2021
$2.10M(+120.4%)
$2.10M(-2.4%)
Sep 2021
-
$2.15M(+2.1%)
Jun 2021
-
$2.11M(+64.6%)
Mar 2021
-
$1.28M(+34.4%)
Dec 2020
$953.00K(+34.4%)
$953.00K(-32.2%)
Sep 2020
-
$1.41M(+47.6%)
Jun 2020
-
$952.00K(+39.2%)
Mar 2020
-
$684.00K(-3.5%)
Dec 2019
$709.00K(-50.0%)
$709.00K(-7.1%)
Sep 2019
-
$763.00K(-29.4%)
Jun 2019
-
$1.08M(-34.6%)
Mar 2019
-
$1.65M(+16.5%)
Dec 2018
$1.42M(+114.0%)
$1.42M
Dec 2017
$662.00K
-

FAQ

  • What is IDEAYA Biosciences, Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for IDEAYA Biosciences, Inc.?
  • What is IDEAYA Biosciences, Inc. annual accounts payable year-on-year change?
  • What is IDEAYA Biosciences, Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for IDEAYA Biosciences, Inc.?
  • What is IDEAYA Biosciences, Inc. quarterly accounts payable year-on-year change?

What is IDEAYA Biosciences, Inc. annual accounts payable?

The current annual accounts payable of IDYA is $15.42M

What is the all-time high annual accounts payable for IDEAYA Biosciences, Inc.?

IDEAYA Biosciences, Inc. all-time high annual accounts payable is $15.42M

What is IDEAYA Biosciences, Inc. annual accounts payable year-on-year change?

Over the past year, IDYA annual accounts payable has changed by +$8.82M (+133.72%)

What is IDEAYA Biosciences, Inc. quarterly accounts payable?

The current quarterly accounts payable of IDYA is $18.43M

What is the all-time high quarterly accounts payable for IDEAYA Biosciences, Inc.?

IDEAYA Biosciences, Inc. all-time high quarterly accounts payable is $18.43M

What is IDEAYA Biosciences, Inc. quarterly accounts payable year-on-year change?

Over the past year, IDYA quarterly accounts payable has changed by +$5.87M (+46.68%)
On this page